Home / Markets / Capital Market News / Aurobindo Pharma consolidated net profit declines 10.28% in the June 2025 quarter

Aurobindo Pharma consolidated net profit declines 10.28% in the June 2025 quarter

Last Updated : Aug 05 2025 | 9:07 AM IST

Sales rise 4.48% to Rs 7791.77 crore

Net profit of Aurobindo Pharma declined 10.28% to Rs 824.75 crore in the quarter ended June 2025 as against Rs 919.22 crore during the previous quarter ended June 2024. Sales rose 4.48% to Rs 7791.77 crore in the quarter ended June 2025 as against Rs 7457.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales7791.777457.65 4 OPM %20.5721.70 -PBDT1612.501728.07 -7 PBT1206.801323.89 -9 NP824.75919.22 -10

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content